Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 3Thoracic 2Gynecologic 2Genitourinary 2Gastrointestinal 2Sarcoma 1Endocrine 1Dermatologic 1CNS 1

Conditions

Small Cell Lung Carcinoma 1Melanoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 551Pemetrexed 404Cisplatin 401Paclitaxel 273Docetaxel 255Gemcitabine 218pembrolizumab 191Bevacizumab 190Erlotinib Hydrochloride 184Radiotherapy 181Etoposide 147durvalumab 140Nivolumab 134Drug Therapy 127osimertinib 107atezolizumab 92Gefitinib 74Radiosurgery 72anlotinib 69Vinorelbine 68tislelizumab 52Irinotecan 51Ipilimumab 50130-nm albumin-bound paclitaxel 50Taxes 48Surgical Procedures, Operative 46Cetuximab 46sintilimab 45Albumin-Bound Paclitaxel 45apatinib 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × guadecitabine × Thoracic × Clear all
NCT03913455 2023-12-20

Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer

Hoosier Cancer Research Network

Phase 2 Completed
24 enrolled 13 charts
Thoracic

Small Cell Lung Carcinoma

NCT04250246 2020-01-31

NIBIT-ML1

Italian Network for Tumor Biotherapy Foundation

Phase 2 Unknown
184 enrolled
DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡